Market revenue in 2023 | USD 579.4 million |
Market revenue in 2030 | USD 1,018.6 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 72.09% in 2023. Horizon Databook has segmented the India high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare reforms in India are underway, as the healthcare expenditure is expected to grow at a rate of over 15% each year. However, healthcare expenditure was as low as 1.28% of the GDP in 2019. According to Cancer India, in 2018, over 2.25 million people had cancer in India and 1.1 million new cases are reported every year.
Government initiatives, such as Ayushman Bharat and PMNRF, are anticipated to improve public access to oncology diagnostics and treatment. India has the second largest aging population in the world. By 2025, around 1 2% o f the Indian population will be over 60 years.
In addition, rising incidence of cancer, diabetes, obesity, and cardiovascular diseases is exerting greater demand o n the healthcare infrastructure. Furthermore, development of generics industry, which provides products at competitive prices, is fueling the growth o f India high potency active pharmaceutical ingredients market.
Horizon Databook provides a detailed overview of country-level data and insights on the India high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into India high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account